Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

25 Apr 2016 07:00

RNS Number : 1437W
Biome Technologies PLC
25 April 2016
 

25 April 2016

 

 

Biome Technologies plc

("Biome", the "Company" or the "Group")

 

Trading Update

 

 

In advance of its Annual General Meeting today, Biome, a leading bioplastics and radio frequency technology business, is pleased to announce a trading update for the three months ended 31 March 2016.

 

Total Group revenues achieved for the first three months of the year were ÂŁ1.1m, in line with the same quarter last year (2015: ÂŁ1.1m).

 

The Group made a small profit before interest, tax, depreciation, amortisation, and share option charges in this quarter (based on unaudited management accounts).

 

The Group's cash position as at 31 March 2016 was ÂŁ1.6m (31 December 2015: ÂŁ1.6m) reflecting the current trading activity. Increases in capitalised development spend were offset by working capital reductions.

 

Bioplastics Division

Revenues in the Bioplastics division in Q1 2016 were ÂŁ0.2m (Q1 2015: ÂŁ0.5m) reflecting the timings of campaign production runs in the US single-serve coffee market. The new temperature-tolerant material underwent final customer production run trials in the quarter and revenues of this product are expected to build over the coming months.

 

Further progress has been made on the development of a biodegradable non-woven mesh. The Group also received further government funding of ÂŁ0.7m in the quarter, highlighted in the 2015 full year results, to continue its medium term development work on bio-based materials.

 

Stanelco RF Technologies Division

Revenues for Q1 2016 in the RF Technologies division were ÂŁ0.9m (Q1 2015: ÂŁ0.6m). Good revenue levels were supported by orders for fibre optic furnaces and activity associated with the ÂŁ1.5m contract to supply advanced analytical equipment to a customer in a regulated industry. Both systems for this contract are due to be delivered before the end of June 2016.

 

Outlook

Biome continues to make good progress against the strategy as set out in the Group's full year results in March 2016 and against this background the Board remains confident in the Group's outlook for the remainder of the year.

 

 

 

 

- Ends -

 

 

 

 

For further information please contact:

 

Biome Technologies plc

 

Paul Mines, Chief Executive Officer

 

Declan Brown, Group Finance Director

 

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

 

David Hart/Alex Brearley (Nominated Adviser)

Chris Crawford/Kelly Gardiner (Broker)

 

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

 

FTI Consulting

 

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKQDQKBKBPQB
Date   Source Headline
27th Mar 20192:05 pmRNSSecond Price Monitoring Extn
27th Mar 20192:00 pmRNSPrice Monitoring Extension
13th Mar 20191:54 pmRNSHoldings in Company
24th Jan 20197:00 amRNSPre-close Trading Statement
31st Dec 20187:00 amRNSTotal Voting Rights
10th Dec 20182:35 pmRNS2017 Long Term Incentive Plan - First Vesting
6th Dec 20187:00 amRNSGrant funding from Innovate UK
23rd Nov 201812:38 pmRNSBiome to present at Mello London
1st Nov 20187:00 amRNSTrading update
3rd Sep 20187:00 amRNSInterim Results
23rd Jul 20187:00 amRNSTrading Update
31st May 20185:00 pmRNSTotal Voting Rights
2nd May 20184:13 pmRNSIssue of shares to directors & PDMR shareholdings
2nd May 20183:27 pmRNSProposed issue of shares to directors and dealings
24th Apr 201810:40 amRNSResult of Annual General Meeting
24th Apr 20187:00 amRNSTrading update
28th Mar 20181:52 pmRNSNotice of AGM and Annual Report and Accounts
27th Mar 20187:00 amRNSPreliminary Results
19th Feb 20182:05 pmRNSSecond Price Monitoring Extn
19th Feb 20182:00 pmRNSPrice Monitoring Extension
25th Jan 20187:00 amRNSPre-close Trading Statement
21st Dec 20177:00 amRNSNew LTIP and option grant
1st Nov 20177:00 amRNSTrading Update
4th Sep 20177:00 amRNSHalf-year Report
26th Jul 20179:30 amRNSDirector/PDMR Shareholding
25th Jul 20174:50 pmRNSDirector/PDMR Shareholding
24th Jul 20177:00 amRNSTrading Update
24th Apr 201710:45 amRNSResult of AGM
24th Apr 20177:00 amRNSTrading Update
31st Mar 20172:50 pmRNSNotice of AGM and Annual Report and Accounts
29th Mar 20177:00 amRNSPreliminary Results
20th Jan 20177:00 amRNSPre-close Trading Statement
18th Jan 20177:00 amRNSSettlement Agreement
2nd Nov 20167:00 amRNSTrading Update
31st Aug 20167:00 amRNSHalf-year Report
27th Jun 20167:00 amRNSTrading Update
25th Apr 201612:34 pmRNSResult of Annual General Meeting
25th Apr 20167:00 amRNSTrading Update
1st Apr 201610:42 amRNSNotice of AGM and Annual Report and Accounts
30th Mar 20167:00 amRNSFinal Results
26th Jan 20167:00 amRNSPre-close Trading Statement
3rd Nov 20157:00 amRNSTrading Statement
2nd Sep 20157:00 amRNSInterim Results
23rd Jul 20157:00 amRNSTrading Update
19th Jun 20159:00 amRNSNew Contract
27th Apr 20154:46 pmRNSResult of AGM
27th Apr 20157:00 amRNSTrading Update
27th Mar 20153:43 pmRNSNotice of Annual General Meeting
25th Mar 20157:00 amRNSPreliminary Results
19th Feb 20153:26 pmRNSFunding Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.